Cognition-Weighted Multimodal MRI and FDG-PET Features for Classification of Mild Cognitive Impairment, Alzheimer’s Disease, and Frontotemporal Dementia
Translational Insights · 2026
DOI: 10.53941/ti.2026.100011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Insights, 2026. Verfasst von Sunil Kumar Khokhar und 12 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Background
Differentiating between mild cognitive impairment (MCI), Alzheimer’s disease (AD), and frontotemporal dementia (FTD) subtypes remains a clinical challenge due to overlapping cognitive symptoms, structural atrophy, and metabolic patterns, especially in the early stages. Multimodal classification approaches integrating neuroimaging and cognitive scores may offer early, accurate characterization and, subsequently, improved diagnostic precision.
Methods
In this study, we included 100 participants (50 AD, 30 FTD [14 behavioral variant FTD (bvFTD) and 16 primary progressive aphasia (PPA)], and 20 MCI) who underwent simultaneous structural MRI and FDG-PET imaging. Cortical thickness (CTH) from anatomical MRI and standardized uptake values from FDG-PET were extracted using FreeSurfer and PETSurfer pipelines, respectively. CTH and FDG-PET features were combined into a single vector through a logistic weighting function derived from ACE-III scores, capturing the progressive nature of cognitive decline in dementia. A Naive Bayes classifier was then trained to differentiate diagnostic groups based on the merged features.
Results
The model achieved classification accuracies of 83% for MCI vs. dementia (AD + FTD), 85% for MCI vs. FTD, 87% for MCI vs. PPA, 71% for MCI vs. bvFTD, 64% for MCI vs. AD, and 69% for AD vs. FTD. The overall classification accuracy was 68%, with the highest discriminative performance observed in separating MCI from FTD subtypes.
Conclusions
This study presents a novel, cognition-weighted multimodal approach combining structural and metabolic imaging to enhance the classification of neurodegenerative syndromes. Findings from this study underscore the potential of integrating ACE-III scores with neuroimaging biomarkers to accurately characterize and differentiate early-stage MCI, AD, and FTD variants.
Zitieren
APA
Khokhar, S. K., Misra, R., Kumar, M., Arshad, F., Thanissery, N., Kumar, S., Manae, T., Ramakrishnan, S., Haris, M., Mangalore, S., Alladi, S., Gandhi, T. K., & Bharath, R. D. (2026). Cognition-Weighted Multimodal MRI and FDG-PET Features for Classification of Mild Cognitive Impairment, Alzheimer’s Disease, and Frontotemporal Dementia. Translational Insights. https://doi.org/10.53941/ti.2026.100011
Vancouver
Khokhar SK, Misra R, Kumar M, Arshad F, Thanissery N, Kumar S, et al. Cognition-Weighted Multimodal MRI and FDG-PET Features for Classification of Mild Cognitive Impairment, Alzheimer’s Disease, and Frontotemporal Dementia. Translational Insights. 2026. doi:10.53941/ti.2026.100011
BibTeX
@article{Khokhar2026,
author = {Khokhar, Sunil Kumar and Misra, Rohit and Kumar, Manoj and Arshad, Faheem and Thanissery, Nithin and Kumar, Sandeep and Manae, Tejaswini and Ramakrishnan, Subasree and Haris, Mohammad and Mangalore, Sandhya and Alladi, Suvarna and Gandhi, Tapan Kumar and Bharath, Rose Dawn},
title = {Cognition-Weighted Multimodal MRI and FDG-PET Features for Classification of Mild Cognitive Impairment, Alzheimer’s Disease, and Frontotemporal Dementia},
journal = {Translational Insights},
year = {2026},
doi = {10.53941/ti.2026.100011}
}
EUVIMED